Micha Srour

728 total citations
27 papers, 112 citations indexed

About

Micha Srour is a scholar working on Hematology, Oncology and Immunology. According to data from OpenAlex, Micha Srour has authored 27 papers receiving a total of 112 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Hematology, 6 papers in Oncology and 6 papers in Immunology. Recurrent topics in Micha Srour's work include Hematopoietic Stem Cell Transplantation (11 papers), Acute Myeloid Leukemia Research (9 papers) and Herpesvirus Infections and Treatments (3 papers). Micha Srour is often cited by papers focused on Hematopoietic Stem Cell Transplantation (11 papers), Acute Myeloid Leukemia Research (9 papers) and Herpesvirus Infections and Treatments (3 papers). Micha Srour collaborates with scholars based in France, Switzerland and Belgium. Micha Srour's co-authors include Tamim Alsuliman, Ibrahim Yakoub‐Agha, David Beauvais, Léonardo Magro, Didier Blaise, Michael Hudecek, Patrice Chevallier, Hermann Einsele, Valérie Coiteux and Sophia Danhof and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and The Lancet Oncology.

In The Last Decade

Micha Srour

23 papers receiving 111 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Micha Srour France	7	43	33	26	21	18	27	112
Eva Bubanská Slovakia	7	34 0.8×	30 0.9×	21 0.8×	22 1.0×	27 1.5×	13	110
Colleen Timlin United States	5	49 1.1×	22 0.7×	14 0.5×	10 0.5×	10 0.6×	14	99
Satoshi Kaito Japan	7	61 1.4×	46 1.4×	42 1.6×	69 3.3×	31 1.7×	22	156
Nick de Jonge Netherlands	6	52 1.2×	43 1.3×	21 0.8×	46 2.2×	24 1.3×	8	145
Elisa Roldán Spain	6	47 1.1×	21 0.6×	22 0.8×	8 0.4×	17 0.9×	18	97
Yoshitaka Asakura Japan	6	26 0.6×	33 1.0×	20 0.8×	23 1.1×	31 1.7×	11	126
Mitsuhiro Yuasa Japan	6	51 1.2×	38 1.2×	11 0.4×	18 0.9×	17 0.9×	27	136
Kevin Jestice United Kingdom	6	85 2.0×	36 1.1×	15 0.6×	22 1.0×	46 2.6×	8	178
Divya Koura United States	6	46 1.1×	49 1.5×	9 0.3×	26 1.2×	13 0.7×	18	105
Milagros González‐Rivera Spain	5	31 0.7×	9 0.3×	65 2.5×	16 0.8×	18 1.0×	5	134

Countries citing papers authored by Micha Srour

Since Specialization

Citations

This map shows the geographic impact of Micha Srour's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Micha Srour with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Micha Srour more than expected).

Fields of papers citing papers by Micha Srour

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Micha Srour. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Micha Srour. The network helps show where Micha Srour may publish in the future.

Co-authorship network of co-authors of Micha Srour

This figure shows the co-authorship network connecting the top 25 collaborators of Micha Srour. A scholar is included among the top collaborators of Micha Srour based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Micha Srour. Micha Srour is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Sanz, Jaime, Gesine Bug, Charles Craddock, et al.. (2025). Measurable residual disease-guided interventions in patients with acute myeloid leukaemia undergoing allogeneic haematopoietic cell transplantation: best practice recommendations from the European Society for Blood and Marrow Transplantation Practice Harmonisation and Guidelines Committee. The Lancet Oncology. 26(11). e586–e596.

Brissot, Éolia, Myriam Labopin, Hélène Labussière, et al.. (2024). Post-transplant cyclophosphamide versus anti-thymocyte globulin after reduced intensity peripheral blood allogeneic cell transplantation in recipients of matched sibling or 10/10 HLA matched unrelated donors: final analysis of a randomized, open-label, multicenter, phase 2 trial. Blood Cancer Journal. 14(1). 31–31. 12 indexed citations

Forcade, Édouard, Marie Robin, Marie‐Thérèse Rubio, et al.. (2024). IDALLO study: A retrospective multicenter study of the SFGM‐TC evaluating the efficacy and safety of ivosidenib in relapsed IDH1‐mutated AML after allogeneic hematopoietic cell transplantation. HemaSphere. 8(3). e44–e44.

Alsuliman, Tamim, Nicolas Stocker, Jean El Cheikh, et al.. (2024). Sexually transmitted infections in the context of haematological malignancies. The Lancet Haematology. 11(10). e792–e802. 1 indexed citations

Alsuliman, Tamim, Jacques Olivier Bay, Yves Béguin, et al.. (2024). Toxicités hématologiques après CAR-T cells, recommandations de la Société francophone de greffe de moelle et de thérapie cellulaire (SFGM-TC). Bulletin du Cancer. 112(1). S103–S110. 1 indexed citations

Srour, Micha, Tamim Alsuliman, Julien Labreuche, et al.. (2023). Nilotinib efficacy and safety as salvage treatment following imatinib intolerance and/or inefficacy in steroid refractory chronic graft-versus-host-disease (SR-cGVHD): a prospective, multicenter, phase II study on behalf of the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC). Bone Marrow Transplantation. 58(4). 401–406. 4 indexed citations

Magro, Léonardo, David Beauvais, Micha Srour, et al.. (2023). High frequency of cutaneous eruptions within the first year after allogeneic hematopoietic stem cell transplantation. SHILAP Revista de lepidopterología. 2(3). 456–464. 1 indexed citations

Mohty, Mohamad, Franco Locatelli, Didier Blaise, et al.. (2023). Resolution of Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome (VOD/SOS) with Defibrotide Following HCT in Adult and Pediatric Patients: Pooled Analysis of Defifrance and EBMT PASS Registries. Blood. 142(Supplement 1). 3527–3527. 1 indexed citations

Yakoub‐Agha, Ibrahim, Nassima Ramdane, Micha Srour, et al.. (2022). Impact of Defibrotide in the Prevention of Acute Graft-Versus-Host Disease Following Allogeneic Hematopoietic Cell Transplantation. Annals of Pharmacotherapy. 56(9). 1007–1015. 4 indexed citations

10.

Drumez, Élodie, Valérie Coiteux, Léonardo Magro, et al.. (2022). Single-agent 5-azacytidine as post-transplant maintenance in high-risk myeloid malignancies undergoing allogeneic hematopoietic cell transplantation. Annals of Hematology. 101(6). 1321–1331. 6 indexed citations

11.

Poulain, Stéphanie, Emmanuelle Jeanpierre, Micha Srour, et al.. (2022). Successful and safe response to ibrutinib alone in treating relapsed Waldenström macrogobulinemia and related acquired von Willebrand syndrome: an option to consider. Leukemia & lymphoma. 63(13). 3100–3104. 1 indexed citations

12.

Faure, Emmanuel, Hélène Behal, Micha Srour, et al.. (2022). The promising efficacy of a risk-based letermovir use strategy in CMV-positive allogeneic hematopoietic cell recipients. Blood Advances. 7(5). 856–865. 9 indexed citations

13.

Srour, Micha, Federica Giannotti, Jean Roy, et al.. (2022). Non-prise de greffe, dysfonctionnement du greffon et érythroblastopénie : mise à jour des définitions, outils diagnostiques et prise en charge : recommandation de la SFGM-TC. Bulletin du Cancer. 110(2). S67–S78.

14.

Robin, Marie, Thomas Rémen, Amandine Luc, et al.. (2021). On Behalf of the SFGM-TC: Retrospective Comparison of Reduced and Higher Intensity Conditioning for High-Risk Myelodysplastic Syndrome Treated With Allogeneic Stem-Cell Transplantation. Clinical Lymphoma Myeloma & Leukemia. 22(1). 34–43. 3 indexed citations

15.

Cornillon, Jérôme, Élisabeth Daguenet, Olivier Tournilhac, et al.. (2021). Allogeneic hematopoietic stem cell transplantation from unmanipulated haploidentical donor and unrelated cord blood for T-cell lymphoma: a retrospective study from the Société Francophone de Greffe de Moelle et de Therapie Cellulaire. Bone Marrow Transplantation. 56(11). 2849–2856. 1 indexed citations

16.

Alsuliman, Tamim, et al.. (2020). A review of potential treatments to date in COVID-19 patients according to the stage of the disease. Current Research in Translational Medicine. 68(3). 93–104. 15 indexed citations

17.

Alsuliman, Tamim, et al.. (2020). COVID-19 paraclinical diagnostic tools: Updates and future trends. Current Research in Translational Medicine. 68(3). 83–91. 12 indexed citations

18.

Alsuliman, Tamim, Léonardo Magro, Valérie Coiteux, et al.. (2019). The concurrent administration of imatinib with extracorporeal photopheresis leads to complete and durable responses in patients with refractory sclerotic type chronic graft-versus-host disease. Current Research in Translational Medicine. 68(2). 71–76. 5 indexed citations

19.

Raus, Nicole, et al.. (2019). Modalités de capture des anomalies cytogénétiques et moléculaires pour la leucémie aiguë, le myélome multiple, le syndrome myélodysplasique, le syndrome myéloprolifératif et le syndrome myélodysplasique/myéloprolifératif : recommandations de la Société francophone de greffe de moelle et de thérapie cellulaire (SFGM-TC). Bulletin du Cancer. 107(1). S52–S61. 1 indexed citations

20.

Picard, Anne, Marie-Noëlle Varlet, Micha Srour, et al.. (2010). Three-dimensional sonographic diagnosis of abdominal wall endometriosis: a useful tool?. Fertility and Sterility. 95(1). 289.e1–289.e4. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact